Reported 2 days ago
Berenberg Bank has maintained a Buy rating on Sanofi (SNY), setting a price target of €118. This decision follows Sanofi's presentation at the Goldman Sachs Healthcare Conference, where the company showcased growth prospects, particularly in Specialty Care. Analyst Luisa Hector noted the potential for dupilumab to achieve significant revenue and highlighted recent product launches that contribute to a positive outlook for the company.
Source: YAHOO